Modulation of the Apoptosis Gene Bcl-x Function Through Alternative Splicing.

Area of Science:

• Molecular Biology
• Cell Biology
• Genetics

Background:

• Apoptosis is crucial for cell homeostasis, development, and disease.
• Bcl-x, a Bcl-2 family protein, regulates apoptosis via alternative splicing.
• Two isoforms, Bcl-xL (anti-apoptotic) and Bcl-xS (pro-apoptotic), arise from Bcl-x alternative splicing.

Purpose of the Study:

• To investigate the role of Bcl-x alternative splicing in cell survival and disease.
• To explore the mechanisms by which Bcl-x isoforms influence apoptosis.
• To identify therapeutic strategies targeting Bcl-x splicing in cancer and diabetes.

Main Methods:

• Analysis of Bcl-x alternative splicing events.
• Investigation of splice factors, signaling pathways, and transcription factors influencing Bcl-x splicing.
• Examination of Bcl-x isoform expression in cancer and diabetes models.

Main Results:

• Bcl-xL inhibits apoptosis, while Bcl-xS promotes it.
• Alternative splicing of Bcl-x is modulated by splice factors, transcription factors, and cytokines.
• Dysregulated Bcl-x splicing contributes to cancer (chemotherapy resistance) and diabetes (β-cell apoptosis).

Conclusions:

• The Bcl-xL/Bcl-xS splicing ratio is critical for cell fate.
• Targeting splice factors, transcription factors, and signaling pathways offers a therapeutic approach for cancer and diabetes.
• Understanding Bcl-x alternative splicing is key to developing novel treatments.